Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Medtronic
Cipla
Accenture
Dow
Healthtrust
Johnson and Johnson
Harvard Business School
Novartis
Covington

Generated: February 19, 2018

DrugPatentWatch Database Preview

FREAMINE III 8.5% Drug Profile

« Back to Dashboard

When do Freamine Iii 8.5% patents expire, and what generic alternatives are available?

Freamine Iii 8.5% is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in FREAMINE III 8.5% is amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate. There are three hundred and forty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate profile page.
Summary for FREAMINE III 8.5%
Drug patent expirations by year for FREAMINE III 8.5%
Pharmacology for FREAMINE III 8.5%
Ingredient-typeAmino Acids
Drug ClassAmino Acid

US Patents and Regulatory Information for FREAMINE III 8.5%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun FREAMINE III 8.5% amino acids INJECTABLE;INJECTION 016822-004 Approved Prior to Jan 1, 1982 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
B Braun FREAMINE III 8.5% W/ ELECTROLYTES amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate INJECTABLE;INJECTION 016822-007 Jul 1, 1988 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
QuintilesIMS
US Department of Justice
UBS
Moodys
Baxter
Cipla
Federal Trade Commission
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot